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and these are mainly found in Asians, thus explaining why 
the IFN-γ autoantibodies are almost exclusively found in 
individuals from Asia or Asian descent [4–6]. We describe 
the first case of a patient from African descent that devel-
oped a severe opportunistic infection due to the presence of 
IFN-γ autoantibodies.
Case presentation and discussion
We analysed a 38-year-old Surinamese woman with exten-
sive cervical lymphadenitis and disseminated histoplasmo-
sis for primary immunodeficiency. Her case report has been 
described before because of the remarkable presentation of 
the infection [7]. In short, she presented in early 2004 with 
a 4-month history of painful fistulating cervical mass, alo-
pecia (Fig. 1), difficulty swallowing, fever, and weight loss. 
Her medical history included beta-thalassemia minor and 
blindness due to refractory glaucoma after panuveitis of both 
eyes. She is Surinamese from African descent. She immi-
grated to the Netherlands 10 years before first presentation 
and had last visited Suriname 3 years before presentation. 
On examination, an extensive cervical mass in the posterior 
triangle of her neck with firm induration and two draining 
fistulas, a shallow ulcer at the right side of the mouth, a 
pronounced swelling of the buccal mucosa (Fig. 1) and tris-
mus was noted. CT scan of the neck showed extension of 
suppurative lymphadenitis into the retropharyngeal space 
(Fig. 1c). An X-ray of the thorax was normal; ultrasound 
of the abdomen revealed moderate hepatosplenomegaly. 
Laboratory examination revealed an erythrocyte sedimen-
tation rate > 140 mm, hemoglobulin 5.5 mmol/l, MCV 77 fl, 
and leucocytosis 25.3 × 109/l. She was HIV negative, had 
no MBL mutations and had normal CD4 + (920/mm3) and 
CD8 + (1028/mm3) lymphocyte counts. Normal numbers 
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Introduction
Autoantibodies against IFN-γ can lead to infections with 
opportunistic microbes, especially non-tuberculous myco-
bacteria. These autoantibodies directed against IFN-γ are 
thought to arise due to the 100% homology between peptides 
of the IFN-γ protein and the Aspergillus spp Noc2 proteins 
[1], which can be recognised by persons with certain haplo-
types. A few HLA haplotypes have been found to be associ-
ated with the development of IFN-γ autoantibodies [2, 3], 
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and percentages of B cells were present in blood and bone 
marrow. Leukocytes were increased initially and after that 
were stable at 4200/mm3. A lymph node biopsy revealed 
a necrotizing lymphadenitis with structures suggestive of 
yeasts. No granuloma was seen. Cultures of blood, abscess 
fluid and cervical lymph node biopsy grew Histoplasma 
capsulatum. The diagnosis of cervical lymphadenitis and 
chronic disseminated histoplasmosis was made. She received 
itraconazole 200 mg twice daily and reached adequate serum 
titres. After 2 weeks the fever subsided and she made a slow 
and steady recovery in the course of a year. Itraconazole was 
continued for another year and in a follow-up of 6 years there 
were no signs of recurrence.
There are several primary immunodeficiencies that 
predispose to invasive or chronic fungal diseases, such 
as defects in the fungal recognition pathway (DECTIN1, 
CARD9) and IL-17 signalling (a.o. in IL-17RA, IL-17F, 
STAT1) for Candida infections, and chronic granulomatous 
disease (CGD) and STAT3 defects predisposing to Asper-
gillus infections [8, 9]. Histoplasmosis on the other hand is 
found in patients with defects in the type 1 cytokine path-
way—that are mainly known for conferring susceptibility to 
infections with mycobacteria and salmonellae [10–14]—as 
well as in defects resulting in combined immunodeficiencies 
that affect the presence of multiple cell types [8]. Apparently 
these different fungal pathogens are controlled or killed by 
different pathways.
Our working diagnosis was, therefore, a partial primary 
immunodeficiency affecting the type 1 cytokine pathway, 
such as a dominant-negative IFN-γR1 mutation, which 
would explain her infection as well as its late onset [13, 15]. 
To examine this we stimulated whole blood with various 
concentrations of lipopolysaccharide (LPS) and interferon 
(IFN)-γ to determine whether innate immune responses were 
affected. The patient’s blood cells showed repeatedly (2005, 
2006, 2009) a good response to LPS, but little or no response 
to IFN-γ as determined by measuring IL-12p40, TNF, and 
IL-10 in the supernatants. When isolating peripheral blood 
mononuclear cells (PBMCs) from her blood we found nor-
mal IFN-γR1 expression on monocytes and that IFN-γ could 
induce STAT1 phosphorylation. Phosphorylated STAT1 was 
found to translocate to the nucleus upon stimulation with 
IFN-γ. Her STAT1 gene was sequenced to rule out a muta-
tion that would allow STAT1 phosphorylation, dimerization 
and subsequent translocation to the nucleus, but that would 
preclude binding of STAT1 to DNA; however, no mutation 
was found. On monocytes we also observed that IFN-γ could 
induce normal CD64 upregulation. This was an indication 
that a factor in the plasma was inhibiting the IFN-γ response. 
Using exchange experiments in which plasma of the patient 
Fig. 1  On clinical examination, 
alopecia (a) and multiple fistula 
of a necrotizing right-sided 
cervical mass (b) are noted. CT 
scanning of the neck (c) reveals 
an inflammatory mass from the 
mucosal space extending to the 
skin from the nasal pharynx 
all the way down to the upper 
thoracic aperture, with multiple 
abscesses including one located 
prevertebral (arrow). The right 
carotid artery and jugular vein 
are taken up in the mass, with 
the vein being compressed. 
The left side shows multiple 
enlarged lymph nodes. The 
graph (d) shows the presence of 
IFN-γ autoantibodies in plasma 
of seven healthy controls (C, 
mean), one patient with a high 
concentration of strongly inhib-
iting IFN-γ autoantibodies (P1), 
the current patient (P2), and 
seven patients with NTM infec-
tions (NTM, mean) as measured 
by ELISA. Plates were coated 
with IFN-γ and plasma was 
allowed to bind before detection 
of the anti-IFN-γ autoantibodies 
with HRP-labelled anti-IgG
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was added to cells from controls and vice versa we were 
able to prove this was the case. Whole exome sequencing 
was performed to identify potential mutations but none were 
found.
At that time the first reports were published [16, 17] on 
an adult-onset immunodeficiency in which autoantibodies 
against IFN-γ were leading to infections with non-tubercu-
lous mycobacteria (NTM) and other opportunistic bacteria 
and fungi [5], nearly completely restricted to individuals 
from Southeast Asia [6]. Although our patient was not of 
Southeast Asian descent her plasma was tested for the pres-
ence of antibodies against IFN-γ, these initial tests (on fresh 
samples in 2009) did not show it to contain more antibodies 
against IFN-γ than those of controls. Protein sequencing of 
the IFN-γ-binding fraction isolated from plasma did reveal 
antibodies. At a later time point (in 2014) inhibiting IFN-γ 
autoantibodies were detectable (U-CyTech bioassay), but at 
a concentration 200 lower, and a factor 16 less effective, than 
those in an Asian patient known to produce strongly inhibit-
ing IFN-γ autoantibodies. Currently, IFN-γ autoantibodies 
in her plasma are readily detectable by ELISA (Fig. 1d), and 
these neutralizing IFN-γ autoantibodies were shown to be 
of the IgG class. The IFN-γ autoantibodies were shown in a 
bio-assay to block IFN-γ signalling (data not shown).
In a large study in patients with adult-onset immunode-
ficiency due to IFN-γ autoantibodies from Taiwan, limited 
HLA allele polymorphism was observed and HLA types 
A*11:01, B*40:01, DRB1*16:02, and DQB1*05:02 were 
found to be overrepresented [3]. In a follow-up study also 
including patients from Thailand the association with 
DRB1*16:02 and DQB1*05:02 was confirmed while 
also DRB1*15:02 was found to be associated [2]. In our 
patient none of her alleles were present homozygously. 
She had the HLA types: A*02/A*31, B*53:01:01/B*57, 
C*04:01:01/C*18:01, DQA1*01:02:01/DQA1*03:03:01, 
DQB1*02:02/DQB1*06, and DRB1*09/DRB1*13:02:01, 
so no overlap was seen with the HLA types in the previous 
studies [2, 3].
Patients with adult-onset immunodeficiency due to IFN-γ 
autoantibodies have been reported with disseminated fungal 
infections before. Disseminated histoplasmosis was found in 
seven of 97 patients from Thailand and Taiwan, while also 
other disseminated fungal infections, with Cryptococcus 
neoformans (in ten patients) and Penicillium marneffei (in 
seven patients), were found [5]. In 20 patients from North-
ern Thailand Penicillium marneffei was the most abundant 
disseminated fungal pathogen, while Cryptococcus and His-
toplasma were also found [18]. No Aspergillus or Candida 
infections were reported in those two studies, confirming the 
observation that was made in patients with genetic defects 
that the control of various fungal pathogens requires dif-
ferent pathways. For the control of Histoplasma T cells, 
monocytes, and macrophages are the critical elements [13], 
while for the control of Aspergillus superoxide formation 
is essential and for the control of Candida the DECTIN1 
and IL-17 pathways are essential. That not a larger propor-
tion of patients with genetic defects in the type 1 cytokine 
pathway or with IFN-γ autoantibodies develop Histoplasma 
infections may have to do with the geographical distribu-
tion of Histoplasma. While NTM are ubiquitously present, 
Histoplasma has a geographically limited distribution as it 
is found mainly in soil that contains large amounts of bird 
or bat excreta [19].
One patient from South Africa, living in the UK, was 
reported with IFN-γ autoantibodies. Whether this patient 
was of African or Asian (or other) descent was not speci-
fied [20]. Our patient is, therefore, the first patient from 
definite African descent who was found to produce IFN-γ 
autoantibodies. Including our patient, in total five patients 
have now been reported that developed IFN-γ autoantibod-
ies that were not of Asian descent [4, 20]. It is important to 
remember that although a patient does not have an Asian 
background, IFN-γ autoantibodies that cause opportunistic 
bacterial or fungal infections may nevertheless be present. 
The autoantibodies in this patient were effectively inhibiting 
IFN-γ signalling but due to their low concentration at onset 
these were initially missed. One should keep in mind that 
patients that develop adult-onset immunodeficiency due to 
autoantibodies against IFN-γ may have a period in which the 
autoantibodies are not present at a high concentration yet but 
are nevertheless clinically relevant.
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